Westinghouse Wins Fuel Contract Extension for Xcel Energy’s Prairie Island Nuclear Generating Plant
Westinghouse Electric Company today announced that it has signed a nuclear fuel and related services contract extension with Xcel Energy for its two pressurized water reactor units at the Prairie Island Nuclear Generating Plant in Red Wing, Minnesota.
“This long-term contract extension confirms Xcel Energy’s confidence in the high reliability of Westinghouse nuclear fuel and our proven design and manufacturing capabilities,” said David Howell, Westinghouse president, Americas Region, and chief growth officer. “This fuel contract extension, as well as the recently announced 10-year outage services contract, reflects our long-standing relationship with Xcel Energy.”
Under the terms of the agreement, Westinghouse will deliver eight regions – or batches of fuel assemblies – of the Westinghouse Vantage+ nuclear fuel design for Prairie Island Units 1&2 over an eight-year period. The extension will commence engineering and fabrication in 2019, with the first fuel delivery in 2020. The majority of these fuel assemblies will feature an innovative fuel solution known as the IFBA/Gad Hybrid fuel assembly design. This combines Westinghouse’s proven Integral Fuel Burnable Absorber (IFBA) fuel rods that use zirconium diboride (ZrB2) as the absorber material with a small number of gadolinia fuel rods to facilitate longer fuel cycles, while significantly reducing fuel cycle costs for the customer.
“Nuclear power plays an important role in Xcel Energy’s clean energy vision of 85% carbon-free generation by 2030,”said Tim O’Connor, Xcel Energy senior vice president and chief nuclear officer. “Our agreement with Westinghouse leverages innovation in fuel design combinations, with minimal regulatory change, while reducing our fuel costs to operate. That’s a win for customers and our supplier partners, and proves nuclear can competitively add value to carbon-free electric production.”
The IFBA fuel rods and fuel assemblies will continue to be manufactured at Westinghouse’s Columbia Fuel Fabrication Facility in Columbia, South Carolina, and the gadolinia fuel rods will be manufactured at Westinghouse’s Västerås Fuel Fabrication Facility in Västerås, Sweden.
Westinghouse Electric Company
Sarah Cassella, +1-412-374-4744
Manager, External Communications
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Clarke Valve Closes $5.5 Million Venture Funding Round Led by OGCI Climate Investments25.9.2018 13:00 | Pressemelding
Clarke Valve today completed the sale of $5.5 million of Series B Preferred Stock to a group of investors led by OGCI Climate Investments. Along with funding from Saudi Aramco Energy Ventures and Chevron Technology Ventures, Clarke has now raised $15.5 million of Series B funding. Clarke’s patented Shutter Valves are typically 1/5th the weight, 1/5th the size and 1/5th the cost of equivalent legacy valves, providing substantial benefits to users of industrial control valves in many industries. In addition, Clarke valves are currently the only control valves in the world to achieve the stringent American Petroleum Institute (API) 641 certification for low fugitive emission performance. Fugitive emissions from legacy valve designs is the cause of significant methane emitted to the atmosphere from industrial facilities. Pratima Rangarajan, CEO of OGCI Climate Investments, said “We are pleased to support the Clarke team in its journey to reach a global market. We believe that the Clarke Va
Analogix Introduces Industry’s Lowest Power eDP TCON with In-Cell Touch for Latest Generation Notebooks25.9.2018 13:00 | Pressemelding
Analogix Semiconductor, Inc. today announced its ANX2403, the industry’s lowest power Full HD embedded DisplayPort™ 1.4 (eDP) timing controller (TCON) with panel self-refresh (PSR), VESA DisplayHDR™ 400 support, and in-cell finger and active stylus touch for notebook PCs with graphics display resolution up to 1920x1280. Leveraging Analogix’s technology leadership in low-power processes, the ANX2403 reduces the Full HD 60Hz power consumption to 60mW using 28nm process technology, a 35% reduction over the 40nm technology and more than 50% reduction over the 55nm technology, becoming the lowest power TCON in the industry. Moreover, the ANX2403 supports Intel low refresh rate (LRR) and PSR2 for even further power reductions. “The ANX2403 brings together our capabilities in low-power processes, in-cell touch, and high-dynamic-range (HDR) technology, offering the lowest power consumption to date, better image performance, and thinner panels with reduced bezels at a lower cost to display pane
Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC25.9.2018 12:32 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced results from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial, demonstrating that ALUNBRIG reduced the risk of disease progression or death, known as progression-free survival (PFS), as assessed by a blinded independent review committee (BIRC), by more than fifty percent compared to crizotinib in adults with anaplastic lymphoma kinase-positive (ALK+) locally advanced or metastatic non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. Findings from the first interim analysis of the ALTA-1L trial will be presented during the Presidential Symposium at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC) in Toronto on Tuesday, September 25, 2018. The data were also simultaneously published online in The New England Journal of Medicine. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSC
Softomotive and Enate Partner to Help Clients Orchestrate Workflows across Their RPA Ecosystem25.9.2018 12:15 | Pressemelding
Softomotive, a leading Robotic Process Automation (RPA) vendor, has announced a strategic partnership with Enate, the pioneering Robotic Service Orchestration (RSO) provider. Together, Softomotive and Enate will allow business enterprises of all sizes to go further and faster with their automation programmes, achieving greater efficiency through orchestration of workflows between human employees and software robots. This partnership will offer Softomotive and Enate’s mutual customers the flexibility to orchestrate workflow between humans and bots whether the enterprise is using just Softomotive bots or more than one RPA provider. “As the RPA market matures, we are finding more and more clients are relying on more than one RPA provider, ” said Marios Stavropoulos, Softomotive’s CEO. “This adds an extra layer of complexity and Softomotive is all about simplifying things for our clients. This new partnership with Enate will do just that by allowing them to continue to orchestrate combined
Scientist.com Adds Experienced Drug Hunter Mark Herbert to Management Team25.9.2018 12:06 | Pressemelding
Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced today the appointment of Mark Herbert to its senior leadership team. As the company’s chief business officer, he will focus on continuing the company’s rapid growth and expansion into new research areas and countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005077/en/ Scientist-entrepreneur Mark Herbert brings his strong scientific background and business experience to Scientist.com as new Chief Business Officer. (Photo: Business Wire) “The Scientist.com research sourcing platform is revolutionizing how medical research is done,” said Mark Herbert, Scientist.com’s new Chief Business Officer. “I look forward to helping establish new partnerships, expand existing partnerships and advance our goal of delivering an innovative and disruptive marketplace to the global life sciences community.” Mark has 20+ years’ e
OpenGate Capital Signs Exclusivity Agreement to Sell NAKAN to Westlake Chemical Corporation25.9.2018 12:00 | Pressemelding
OpenGate Capital, a global private equity firm, announced today that it has signed an exclusivity agreement with Westlake Chemical Corporation (NYSE: WLK), pursuant to which Westlake has made a binding offer to acquire NAKAN, a global PVC compounding solutions business headquartered in Reims, France. The transaction is valued at $265 million and is anticipated to be completed by early 2019. NAKAN has eight production facilities located in China, France, Germany, Italy, Japan, Mexico, Spain and Vietnam, as well as a world-class research facility in France and application laboratory in the United States. NAKAN products are used in a wide-variety of applications by customers in the automotive, building and construction, and medical industries. OpenGate Capital acquired NAKAN in 2015, through the acquisition of Ivy Group, during the firm’s pre-fund, legacy investment period. Ivy Group, formerly known as Kem One Innovative Vinyls, was acquired through a French administration process that or